Netherlands· NL-40b6a5459e6f

Pollispray 1 mg/ml neusspray, oplossing

A azelastine product containing azelastinehydrochloride, registered in Netherlands by URSAPHARM Benelux B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC R01AC03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about azelastinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Azelastine is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AC03 (azelastine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search azelastine products by name

Azelastine · ATC R01AC03

11 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: AZELASTINEHYDROCHLORIDE
Manufacturer: URSAPHARM Benelux B.V.
Country: Netherlands (NL)
ATC code: R01AC03
ATC class: Azelastine
Defined daily dose: 0.56 mg, N
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
112977

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

201 interactions on record for azelastine.

Graded by severity as the source publishes them — 200 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check azelastine against other medicines How interaction checks work

Azelastine · interactions on record

201 records

200 moderate
1 minor

Most severe, free to view

MetoclopramideA03FA01moderate
DiphenhydraminA04AB05moderate
TriflupromazinA04AD06moderate
NabiloneA04AD11moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Azelastine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All azelastine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Allergodil, Allergospray
Belgium · Allergodil, Azelergo
Bulgaria · Алергодил, Анталерг
Czechia · Allergodil, Allergodil Forte
Germany · Allergo-Azelind, Allergodil
Denmark · Allergodil, Allergodil Forte
Estonia · Allergodil
Spain · Afluon, Afluón
Finland · Lastin
France · Allergodil, Alonest
United Kingdom (Northern Ireland) · Astepro, Azelair
Greece · Afluon
Croatia · Vivialle, Vivispray
Hungary · Allergodil, Allergodil Forte
Ireland · Astepro, Azelastine Eye Drops Mylan Ire Healthcare
Iceland · Astepro, Lastin
Italy · Allergodil, Allespray
Lithuania · Allergodil
Luxembourg · Allergodil, Azelergo
Latvia · Allergodil
Malta · Antalerg Unimed Pharma, Azelastin-Comod
Norway · Lastin
Poland · Acatar Allergy, Allergodil
Portugal · Allergodil, Astepro
Romania · Allegodil, Allergodil
Sweden · Azelastine Omnivision
Slovenia · Alezaxin, Allergodil
Slovakia · Allergodil, Antalerg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b676b520-df7b-4b20-b443-12e421f36c14
GET /v1/drugs/b676b520-df7b-4b20-b443-12e421f36c14?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Neusspray, oplossing",
  "route": "Nasaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h112977_smpc.pdf",
  "strength": null,
  "atc_label": "Azelastine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg112977",
  "excipients": [
    "CITROENZUUR 0-WATER (E 330)",
    "DINATRIUMEDETAAT 2-WATER",
    "DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
    "HYPROMELLOSE (E 464)",
    "NATRIUMCHLORIDE",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "AZELASTINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h112977.pdf",
  "authorised_at": "2015/01/08",
  "procedure_number": "AT/H/0351/002",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "112977",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about azelastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console